Optimizing long-circulating liposomes for delivery of simvastatin to C26 colon carcinoma cells

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of liposome research

• Publication date

  2015-10-02

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.3109/08982104.2014.987787PMID 25487170
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CHARACTERIZATION OF LIPOSOMES

  2015cited by this paper
• HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation.

  2014cited by this paper
• Cytotoxicity of lipophilic statins depends on their combined actions on HIF-1&agr; expression and redox status in B16.F10 melanoma cells

  2014cited by this paper
• Multifunctional polymeric micelles for delivery of drugs and siRNA

  2014cited by this paper
• Preparation of optimized Naproxen nano liposomes using response surface methodology

  2014cited by this paper
• [Effects of statins in cancer].

  2013cited by this paper
• Involvement of oxidative stress in simvastatin-induced apoptosis of murine CT26 colon carcinoma cells.

  2010cited by this paper
• Liposomal pravastatin inhibits tumor growth by targeting cancer-related inflammation.

  2010influential reference
• Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase

  2009cited by this paper
• Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.

  2009cited by this paper
• Cytogenetic status and oxidative DNA-damage induced by atorvastatin in human peripheral blood lymphocytes: standard and Fpg-modified comet assay.

  2008cited by this paper
• Antitumor activity and tumor localization of liposomal glucocorticoids in B16 melanoma-bearing mice.

  2008cited by this paper
• The role of statins in cancer therapy.

  2006cited by this paper
• The Effect of Cholesterol in the Liposome Bilayer on the Stabilization of Incorporated Retinol

  2005cited by this paper
• Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery.

  2005cited by this paper
• Statins and cancer prevention

  2005cited by this paper
• Enhancement of Nitric Oxide Release in Mouse Inflammatory Macrophages Co-cultivated with Tumor Cells of a Different Origin

  2005cited by this paper
• Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy.

  2005cited by this paper
• A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress.

  2005cited by this paper
• Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability.

  2004cited by this paper
• Recruitment of STAT3 for Production of IL-10 by Colon Carcinoma Cells Induced by Macrophage-Derived IL-61

  2004cited by this paper
• A laser-T-jump study of the adsorption of dipolar molecules to planar lipid membranes

  2004cited by this paper
• A comparative study of the in vitro antioxidant activity of statins.

  2003cited by this paper
• Determination of free malondialdehyde in human serum by high-performance liquid chromatography.

  2002influential reference
• Beyond lipid lowering: the role of statins in vascular protection.

  2002cited by this paper
• Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS.

  2001cited by this paper
• Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet.

  2001cited by this paper
• Design of Experiments, Principles and Applications, L. Eriksson, E. Johansson, N. Kettaneh‐ Wold, C. Wikström and S. Wold, Umetrics AB, Umeå Learnways AB, Stockholm, 2000, ISBN 91‐973730‐0‐1, xii + 329 pp.

  2001cited by this paper
• Statins: effects beyond cholesterol lowering.

  2001cited by this paper
• Angiogenesis in cancer and other diseases

  2000cited by this paper
• Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.

  1999cited by this paper
• Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

  1996cited by this paper
• A laser-T-jump study of the adsorption of dipolar molecules to planar lipid membranes

  1988cited by this paper
• Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication.

  1982cited by this paper
• Determination of serum proteins by means of the biuret reaction.

  1949cited by this paper

• Matrix-free microfluidic 3D biomimetic chip for identifying type I collagen on doxorubicin treated MDA-MB-231 cell

  2025cites this paper
• Leveraging ensemble machine learning models (XGBoost and random forest) and genetic algorithms to predict factors contributing to the liposomal entrapment of therapeutics.

  2025cites this paper
• An AQbD-based Optimized and Green Isocratic HPLC Method for the Quantification of Simvastatin in Liposomes: Forced Degradation, Assessment of Drug Content, and Drug Entrapment

  2025cites this paper
• Targeting of M2 macrophages with IL-13-functionalized liposomal prednisolone inhibits melanoma angiogenesis in vivo

  2024influential citation
• Process development of inhalation powders containing simvastatin loaded liposomes using spray drying technology

  2023cites this paper
• Colloidal Drug Delivery of Simvastatin for Prolonged Drug Release and Increased Bioavailability

  2023cites this paper
• Quality by Design Approach in Liposomal Formulations: Robust Product Development

  2022cites this paper
• The Use of the QbD Approach to Optimize the Co-Loading of Simvastatin and Doxorubicin in Liposomes for a Synergistic Anticancer Effect

  2022cites this paper
• Simvastatin Coadministration Modulates the Electrostatically Driven Incorporation of Doxorubicin into Model Lipid and Cell Membranes

  2022cites this paper
• Formulation of simvastatin within high density lipoprotein enables potent tumour radiosensitisation.

  2022cites this paper
• Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis

  2022cites this paper
• Application of the QbD Approach in the Development of a Liposomal Formulation with EGCG

  2021cites this paper
• The potential use of simvastatin for cancer treatment: A review.

  2021cites this paper
• Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression

  2021cites this paper
• A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy

  2021cites this paper
• Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression

  2021cites this paper
• Simvastatin nanosuspensions prepared using a combination of pH-sensitive and timed-release approaches for potential treatment of colorectal cancer

  2021cites this paper
• Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5‐fluorouracil in vivo

  2020cites this paper
• DOCTORAL THESIS TARGETING OF THE PROTUMOR MICROENVIRONMENTAL PROCESSES BY LIPOSOMAL SIMVASTATIN-BASED TREATMENTS IN COLORECTAL CANCER

  2019cites this paper
• Quality by Design Considerations for the Development of Lyophilized Products

  2019cites this paper
• Pharmaceutical Development of Liposomes Using the QbD Approach

  2019cites this paper
• Chronic inflammation evoked by pathogenic stimulus during carcinogenesis

  2019cites this paper
• EGFR-targeted immunoliposomes as a selective delivery system of simvastatin, with potential use in treatment of triple-negative breast cancers.

  2019cites this paper
• Improved pharmacokinetics and reduced side effects of doxorubicin therapy by liposomal co-encapsulation with curcumin

  2019cites this paper
• Development of Formulation and In Vitro Evaluation of Sterically Stabilized (Stealth) Liposomes Containing Selected Anti-Arthritic Drug

  2019cites this paper
• Immunoliposomes with Simvastatin as a Potential Therapeutic in Treatment of Breast Cancer Cells Overexpressing HER2—An In Vitro Study

  2018cites this paper
• In Vivo Double Targeting of C26 Colon Carcinoma Cells and Microenvironmental Protumor Processes Using Liposomal Simvastatin

  2018influential citation
• Liposomal nanocarriers for statins: A pharmacokinetic and pharmacodynamics appraisal

  2018cites this paper
• Optimization of prednisolone-loaded long-circulating liposomes via application of Quality by Design (QbD) approach

  2018cites this paper
• A step forward towards the development of stable freeze-dried liposomes: a quality by design approach (QbD)

  2018cites this paper
• Anti-angiogenic and anti-inflammatory effects of long-circulating liposomes co-encapsulating curcumin and doxorubicin on C26 murine colon cancer cells

  2018cites this paper
• Co-delivery of curcumin and doxorubicin in PEGylated liposomes favored the antineoplastic C26 murine colon carcinoma microenvironment

  2018cites this paper
• Optimization of Conditions for Cyanidin-3-O-Glucoside (C3G) Nanoliposome Production by Response Surface Methodology and Cellular Uptake Studies in Caco-2 Cells

  2017cites this paper
• Nanoliposomes as a Platform for Delivery of Antimicrobials

  2017cites this paper
• Formulation and pharmaceutical development of quetiapine fumarate sustained release matrix tablets using a QbD approach

  2017cites this paper
• Liposomal prednisolone phosphate potentiates the antitumor activity of liposomal 5-fluorouracil in C26 murine colon carcinoma in vivo

  2017cites this paper
• A quality by design approach for the development of lyophilized liposomes with simvastatin

  2017influential citation
• FORMULATION OPTIMIZATION OF PRAVASTATIN LOADED LONG-CIRCULATING LIPOSOMES USING A DESIGN OF EXPERIMENTS

  2016cites this paper
• Exploitation of pleiotropic actions of statins by using tumour-targeted delivery systems

  2015cites this paper
• Chronic in fl ammation evoked by pathogenic stimulus during carcinogenesis

  year unknowncites this paper